Literature DB >> 30852063

Peritoneal MRI in patients undergoing cytoreductive surgery and HIPEC: History, clinical applications, and implementation.

Russell N Low1, Robert M Barone2, Pascal Rousset3.   

Abstract

MR imaging provides considerable advantages in the evaluation of patients with peritoneal metastases. A standardized peritoneal MRI protocol, including diffusion-weighted and gadolinium-enhanced sequences, allows an efficient exploration of small peritoneal tumors that are often missed on other imaging tests. In experienced hands, a dedicated reading allows producing a quantitative and qualitative evaluation of lesional localization to better assist surgeons in the selection of candidates for curative surgery by evaluating the possibility of complete resection, and to plan the surgical procedure. Based on a close collaboration between oncologic surgeon and radiologist, MRI provides a powerful tool for accurate preoperative imaging in patients being considered for curative surgery but also in their surveillance to detect an early recurrence.
Copyright © 2019 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Entities:  

Keywords:  Peritoneal cancer index; Peritoneal carcinomatosis; Peritoneal metastases; Preoperative assessment; Pseudomyxoma peritonei; Resectability

Mesh:

Substances:

Year:  2019        PMID: 30852063     DOI: 10.1016/j.ejso.2019.02.030

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  12 in total

1.  HIPEC Methodology and Regimens: The Need for an Expert Consensus.

Authors:  Aditi Bhatt; Ignace de Hingh; Kurt Van Der Speeten; Martin Hubner; Marcello Deraco; Naoual Bakrin; Laurent Villeneuve; Shigeki Kusamura; Olivier Glehen
Journal:  Ann Surg Oncol       Date:  2021-06-17       Impact factor: 5.344

Review 2.  Primary and metastatic peritoneal surface malignancies.

Authors:  Delia Cortés-Guiral; Martin Hübner; Mohammad Alyami; Aditi Bhatt; Wim Ceelen; Olivier Glehen; Florian Lordick; Robert Ramsay; Olivia Sgarbura; Kurt Van Der Speeten; Kiran K Turaga; Manish Chand
Journal:  Nat Rev Dis Primers       Date:  2021-12-16       Impact factor: 52.329

Review 3.  Advances in the management of peritoneal malignancies.

Authors:  Vahan Kepenekian; Aditi Bhatt; Julien Péron; Mohammad Alyami; Nazim Benzerdjeb; Naoual Bakrin; Claire Falandry; Guillaume Passot; Pascal Rousset; Olivier Glehen
Journal:  Nat Rev Clin Oncol       Date:  2022-09-07       Impact factor: 65.011

4.  Clinical and Radiologic Predictors of a Pathologic Complete Response to Neoadjuvant Chemotherapy (NACT) in Patients Undergoing Cytoreductive Surgery for Colorectal Peritoneal Metastases: Results of a Prospective Multi-center Study.

Authors:  Aditi Bhatt; Pascal Rousset; Nazim Benzerdjeb; Praveen Kammar; Sanket Mehta; Loma Parikh; Gaurav Goswami; Sakina Shaikh; Vahan Kepenekian; Guillaume Passot; Olivier Glehen
Journal:  Ann Surg Oncol       Date:  2020-11-18       Impact factor: 5.344

Review 5.  Treatment of primary and metastatic peritoneal tumors in the Covid-19 pandemic. Proposals for prioritization from the RENAPE and BIG-RENAPE groups.

Authors:  O Glehen; V Kepenekian; O Bouché; L Gladieff; C Honore
Journal:  J Visc Surg       Date:  2020-04-23       Impact factor: 2.043

6.  Influence of peritoneal carcinomatosis on perioperative outcome in palliative gastric bypass for malignant gastric outlet obstruction - a retrospective cohort study.

Authors:  Jan Bednarsch; Zoltan Czigany; Daniel Heise; Henning Zimmermann; Joerg Boecker; Tom Florian Ulmer; Ulf Peter Neumann; Christian Klink
Journal:  World J Surg Oncol       Date:  2020-01-31       Impact factor: 2.754

7.  Adding Value of MRI over CT in Predicting Peritoneal Cancer Index and Completeness of Cytoreduction.

Authors:  Chia-Ni Lin; Weh-Shih Huang; Tzu-Hao Huang; Chao-Yu Chen; Cheng-Yi Huang; Ting-Yao Wang; Yu-San Liao; Li-Wen Lee
Journal:  Diagnostics (Basel)       Date:  2021-04-08

8.  Ultrasound for Preoperatively Predicting Pathology Grade, Complete Cytoreduction Possibility, and Survival Outcomes of Pseudomyxoma Peritonei.

Authors:  Lei Liang; Xuedi Han; Nan Zhou; Hongbin Xu; Jun Guo; Qian Zhang
Journal:  Front Oncol       Date:  2021-09-15       Impact factor: 6.244

9.  Prognostic Value of CEA, CA19-9, CA125, CA724, and CA242 in Serum and Ascites in Pseudomyxoma Peritonei.

Authors:  Lei Liang; Jingyang Fang; Xuedi Han; Xichao Zhai; Yan Song; Yiyan Lu; Qian Zhang; Ruiqing Ma
Journal:  Front Oncol       Date:  2021-10-18       Impact factor: 6.244

10.  Patterns of peritoneal dissemination and response to systemic chemotherapy in common and rare peritoneal tumours treated by cytoreductive surgery: study protocol of a prospective, multicentre, observational study.

Authors:  Aditi Bhatt; Pascal Rousset; Dario Baratti; Daniele Biacchi; Nazim Benzerdjeb; Ignace H J T de Hingh; Marcello Deraco; Vadim Gushchin; Praveen Kammar; Daniel Labow; Edward Levine; Brendan Moran; Faheez Mohamed; David Morris; Sanket Mehta; Aviram Nissan; Mohammad Alyami; Mohammad Adileh; Shoma Barat; Almog Ben Yacov; Kurtis Campbell; Kathleen Cummins-Perry; Delia Cortes-Guiral; Noah Cohen; Loma Parikh; Samer Alammari; Galal Bashanfer; Anwar Alshukami; Kaushal Kundalia; Gaurav Goswami; Vincent van de Vlasakker; Michelle Sittig; Paolo Sammartino; Armando Sardi; Laurent Villeneuve; Kiran Turaga; Yutaka Yonemura; Olivier Glehen
Journal:  BMJ Open       Date:  2021-07-05       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.